North China Pharmaceutical Company Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 2,712.983 million compared to CNY 2,317.300 million a year ago. Operating loss was CNY 36.075 million compared to operating Income of CNY 75.199 million a year ago. Net loss was CNY 57.199 million compared to net income of CNY 66.713 million a year ago. Basic loss per share from continuing operations was CNY 0.035 compared to basic earnings per share from continuing operations of CNY 0.041 a year ago.